William H. Rastetter
Massachusetts Institute of Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by William H. Rastetter.
Toxicology and Applied Pharmacology | 1986
John R. Babson; Sandra Russo-Rodriguez; Ruth V. Wattley; Paul L. Bergstein; William H. Rastetter; Howard L. Liber; Barbara M. Andon; William G. Thilly; Gerald N. Wogan
The in vitro metabolism of fluoranthene (FA) was assessed by incubating 3-[3H]FA, the synthesis of which is described, with rat hepatic microsomal enzymes. Several metabolites including the FA 2,3-diol, FA 2-3,-quinone, 3-OH-FA, 1-OH-FA, and 8-OH-FA were isolated by high-pressure liquid chromatography and identified by comparison of chromatographic properties and uv-visible spectra with those of synthetic standards. The major metabolite produced over the FA concentration range studied (23-233 microM) was FA 2,3-diol, accounting for 29-43% of the total extractable metabolites. This diol was characterized further by high-resolution mass spectroscopy and H-NMR and determined to be identical in structure to the trans-2,3-dihydroxy-2,3-dihydrofluoranthene. The FA 2,3-diol, syn and anti 2,3-diol-1,10b-epoxides, FA 2,3-quinone, and FA 7,8-diol were all shown to be mutagenic toward Salmonella typhimurium TM677. The FA 1,10b-diol and syn and anti FA 1,10b-diol-2,3-epoxides were not mutagenic. The epoxide hydrolase inhibitor, 3,3,3-trichloropropylene oxide, markedly reduced the mutagenic potency of FA while concurrently inhibiting FA 2,3-diol production but not overall FA metabolism. These results suggests that a major metabolic activation pathway of FA resulting in the production of mutagenic species involves the formation of the FA 2,3-diol and the subsequent oxidation of this diol to a FA 2,3-diol-1,10b-epoxide. Another minor activation pathway with mutagenic endpoints may involve the formation of the 7,8-diol.
Tetrahedron Letters | 1982
William H. Rastetter; J. Adams; Jon Bordner
Abstract A stereoselective and chiral synthesis of a precursor to the fungal metabolite sirodesin A ( 1 ) is described. The correct relative and absolute confirugation for intermediate 3 (Scheme 1) is established in a single, highly enantioselective epoxidation.
Tetrahedron Letters | 1982
Jeremiah P. Freeman; Makhluf J. Haddadin; William H. Rastetter; T. Chancellor
Abstract The base-catalyzed hydration of anil 1 affords O-benzoylmandelanilide ( 7 ) rather than hydroxylamine 2 as was previously reported.
Tetrahedron Letters | 1979
William H. Rastetter; John W. Frost
Abstract The mechanism of kinetic resolution of an oxaziridine by brucine is re-examined. Contrary to a currently accepted report, two oxaziridines re-investigated do not transfer oxygen to the tertiary amine, brucine.
Tetrahedron Letters | 1979
William H. Rastetter; Larry J. Nummy
Abstract The synthesis of 3-(β-aminoethyl)benzene oxide ( 7 is described. The failure of 7 to ring close ( 7 → 8 ) is attributed to the low “nucleophilic susceptibility” of the arene oxide.
Tetrahedron Letters | 1979
William H. Rastetter; Dennis P. Phillion
Abstract Macrolide formation from reactive crown ether 1 is driven by the proximate binding of alkoxide and thioester functionalities.
Journal of Organic Chemistry | 1981
William H. Rastetter; Thomas J. Erickson; Michael C. Venuti
Carcinogenesis | 1986
John R. Babson; Sandra Russo-Rodriguez; William H. Rastetter; Gerald N. Wogan
Journal of Organic Chemistry | 1982
William H. Rastetter; Robert B. Nachbar; Sandra Russo-Rodriguez; Ruth V. Wattley; William G. Thilly; Barbara M. Andon; William L. Jorgensen; Mustafa Ibrahim
Journal of the American Chemical Society | 1975
William H. Rastetter